AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Clean Power Hydrogen Plc

Environmental & Social Information Feb 21, 2024

6149_bfr_2024-02-21_82e6eb37-ab65-4afe-972a-00e8ca3a09c8.html

Environmental & Social Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8061D

Clean Power Hydrogen

21 February 2024

A picture containing food, game Description automatically generated

21 February 2024                                                                                         

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

Operational Update

Clean Power Hydrogen plc (AIM: CPH2), the UK-based green hydrogen technology and manufacturing group that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce that it has successfully completed its functional test of the Programme Logic Control ("PLC") of the MFE110 for Northern Ireland Water. The PLC represents the coded programme which automatically operates the MFE110 including shutdown, an important safety feature which originally caused the pausing of the MFE110 Factory Acceptance Test ("FAT") in November 2023.

The successful test was witnessed by Lagan MEICA Limited, the Contractor to Northern Ireland Water, and means the Factory Acceptance Test can progress to the final stages.

A Factory Acceptance Test will be the first customer acceptance and validation of CPH2's scaled electrolyser technology marking a significant milestone in the Company's journey. The PLC can also be used for the Company's 1MW system, the MFE220 which is the Company's flagship product.   

Jon Duffy, CEO of Clean Power Hydrogen commented:

"The successful test of the Programme Logic Control allowing for fully automated operation, signifies an important part of the MFE110's journey to commercial production of hydrogen and medical grade oxygen. While the pausing of the FAT test in November 2023 due to issues regarding the shutdown mechanism were disappointing, I am extremely proud of the team for re-evaluating the important safety shut down measures, and successfully finding a solution which has put us back on track to completing the MFE110 for our customers in the very near-term future."

ENDS

For more information, please contact:

Clean Power Hydrogen plc via Camarco
Jon Duffy, Chief Executive Officer
James Hobson, Chief Financial Officer
Cavendish Capital Markets Limited - NOMAD & Broker
Neil McDonald +44 (0)131 220 9771
Peter Lynch +44 (0)131 220 9772
Adam Rae +44 (0)131 220 9778
Camarco PR + 44(0) 20 3757 4980
Billy Clegg
Owen Roberts
Lily Pettifar

To find out more, please visit: https://www.cph2.com

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

UPDEALAEAEELEFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.